Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

apellis pharmaceuticals

POPULAR ARTICLES

Pharmaceutical Investing

Apellis Pharmaceuticals Announces Collaboration with SFJ Pharmaceuticals® for APL-2 in Hematologic Indications

Apellis Pharmaceuticals’ APL-2 Receives Orphan Drug Designation from the FDA

Apellis Pharmaceuticals Provides Update on Its Phase 3 Program for Patients with Geographic Atrophy

LATEST ARTICLES

Apellis Pharmaceuticals Presents New Data from Ongoing APL-2 Phase 2 Study

Latest News

Heliostar Delivers Strong First Quarter 2025 Results

Silver Crown Royalties Announces Closing of Final Tranche of its Non-Brokered Private Placement

Binding Commitments Received for A$1.0 Million under Convertible Note Placement

First patient dosed in Phase IIb imaging for Brain Mets

Quarterly Activities Report and Appendix 4C